Andrew Scott
Keine laufenden Positionen mehr
Profil
Andrew Scott worked as Vice President of Business Development at Fortress Biotech, Inc. and Vice President of Corporate Development at Oncolix, Inc. He obtained an undergraduate degree from Pace University.
Ehemalige bekannte Positionen von Andrew Scott
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOLIX, INC. | Corporate Officer/Principal | - |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | - |
Ausbildung von Andrew Scott
| Pace University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Oncolix, Inc.
 Oncolix, Inc. Pharmaceuticals: MajorHealth Technology Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX. | Health Technology |
